Addressing wholesale distributor barriers to buprenorphine access: Consensus recommendations from the PhARM-OUD expert panel

Addressing wholesale distributor barriers to buprenorphine access: Consensus recommendations from the PhARM-OUD expert panel

Objective: Less than one-in-four patients with opioid use disorder receive opioid agonist treatment. This is in part due to the fact that less than 60 % of pharmacies stock and dispense buprenorphine products for the treatment of opioid use disorder (OUD). Pharmacies do not stock for many reasons bu...

Full description

Saved in:
Bibliographic Details
Main Authors: Tyler J. Varisco, Douglas Thornton, Taha Hussain, Hannah Fish, Joshua Bolin, David Dadiomov, Ekere J. Essien, Matthew A. Wanat, Diane Ginsburg, Jeanne Waggener, Jeffrey P. Bratberg, Bethany DiPaula, Lucas G. Hill
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:Drug and Alcohol Dependence Reports
Subjects:
Pharmacists
Buprenorphine
Medication systems
Drug and narcotic control
Online Access:http://www.sciencedirect.com/science/article/pii/S2772724625000435
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items